Archive for October, 2019

Recent Rosacea Blog Posts

Rhofade sold to EPI Health

Rhofade sold to EPI Health

Written by on October 16, 2019 in research with 0 Comments

Having been sold just 1 year ago to Aclaris, the topical redness treatment for rosacea, Rhofade has again changed hands – this time to EPI Health. The value of the transaction is around $55m. Rhofade was previously owned by Allergan. What is Rhofade? Rhofade is Oxymetazoline  HCL 1% Cream for the Redness of Rosacea. Officially […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.